Helen of Troy (HELE) Misses Q1 EPS by 52c, Misses on Revenue; Offers Weak Guidance

Helen of Troy (NASDAQ: HELE) reported Q1 EPS of $0.41, $0.52 worse than the analyst estimate of $0.93. Revenue for the quarter came in at $371.7 million versus the consensus estimate of $400.36 million.

GUIDANCE:

Helen of Troy sees Q2 2026 EPS of $0.45-$0.60, versus the consensus of $1.21. Helen of Troy sees Q2 2026 revenue of $408-432 million, versus the consensus of $475 million.

For earnings history and earnings-related data on Helen of Troy (HELE) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Sphere 3D posts $13.8M Q2 loss after Cathedra merger
• Boost Run posts Q2 revenue of $31.1M, up 270% year over year